INS and Alzheimer disease: Alterations in ganglioside metabolism contribute to rare hereditary paraplegia, intellectual disability, Alzheimer’s disease (AD), Parkinson’s disease (PD), insulin sensitivity and diabetes, bacterial toxin susceptibility, and severe lysosomal storage diseases2,3.